Research Roundup


Debbie Rigby rounds up the latest in research news Cardiometabolic parameter change by weight regain on tirzepatide withdrawal in adults with obesity A post hoc analysis of the SURMOUNT-4 trial shows on tirzepatide withdrawal, greater reversal of initial cardiometabolic benefits was observed in participants who regained 25% or more of their initial weight reduction vs

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous An SSSI for clonidine 150mcg
Next ‘Implement them all’